Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Size of low‑density lipoprotein particles in patients after stroke.

Dukát A, Oravec S, Gavorník P, Wawruch M, Sabaka P.

Pol Arch Med Wewn. 2012;122 Suppl 1:30-1. Review. No abstract available.

2.

Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study).

Masulli M, Patti L, Riccardi G, Vaccaro O, Annuzzi G, Ebbesson SO, Fabsitz RR, Howard WJ, Otvos JD, Roman MJ, Wang H, Weissman NJ, Howard BV, Rivellese AA.

Am J Cardiol. 2009 Dec 1;104(11):1516-21. doi: 10.1016/j.amjcard.2009.07.021. Epub 2009 Oct 14.

3.

Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Berger JS, McGinn AP, Howard BV, Kuller L, Manson JE, Otvos J, Curb JD, Eaton CB, Kaplan RC, Lynch JK, Rosenbaum DM, Wassertheil-Smoller S.

Stroke. 2012 Apr;43(4):958-66. doi: 10.1161/STROKEAHA.111.641324. Epub 2012 Feb 2.

4.

Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke.

Okuzumi A, Ueno Y, Shimada Y, Tanaka Y, Miyamoto N, Yamashiro K, Tanaka R, Hattori N, Urabe T.

J Neurol Sci. 2013 Mar 15;326(1-2):83-8. doi: 10.1016/j.jns.2013.01.019. Epub 2013 Feb 12.

PMID:
23414726
5.

Small dense low-density lipoproteins and associated risk factors in patients with stroke.

Zhao CX, Cui YH, Fan Q, Wang PH, Hui R, Cianflone K, Wang DW.

Cerebrovasc Dis. 2009;27(1):99-104. doi: 10.1159/000175768. Epub 2008 Nov 22.

PMID:
19033685
6.

Relation of long-term body weight change to change in lipoprotein particle size in Japanese men and women: the INTERMAP Toyama Study.

Naganuma R, Sakurai M, Miura K, Yoshita K, Morikawa Y, Kido T, Ueshima H, Nakagawa H, Stamler J.

Atherosclerosis. 2009 Sep;206(1):282-6. doi: 10.1016/j.atherosclerosis.2009.01.043. Epub 2009 Feb 12.

PMID:
19264306
7.

Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients.

Le NA, Jin R, Tomassini JE, Tershakovec AM, Neff DR, Wilson PW.

J Am Heart Assoc. 2013 Aug 7;2(4):e000037. doi: 10.1161/JAHA.113.000037.

8.

Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus.

Hayashi Y, Okumura K, Matsui H, Imamura A, Miura M, Takahashi R, Murakami R, Ogawa Y, Numaguchi Y, Murohara T.

Metabolism. 2007 May;56(5):608-13.

PMID:
17445534
9.

Association between LDL particle size and postprandial increase of remnant-like particles in Japanese type 2 diabetic patients.

Takayanagi N, Onuma T, Kato S, Nishiyama K, Nomiyama T, Kawamori R.

Diabetes Res Clin Pract. 2004 Dec;66(3):245-52.

PMID:
15536021
10.

Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667.

PMID:
11478431
11.

Lipoprotein particle profiles mark familial and sporadic human longevity.

Heijmans BT, Beekman M, Houwing-Duistermaat JJ, Cobain MR, Powell J, Blauw GJ, van der Ouderaa F, Westendorp RG, Slagboom PE.

PLoS Med. 2006 Dec;3(12):e495.

12.

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.

Circulation. 2006 Mar 28;113(12):1556-63. Epub 2006 Mar 13.

13.

Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease.

Tosheska K, Labudovic D, Jovanova S, Jaglikovski B, Alabakovska S.

Bosn J Basic Med Sci. 2011 Aug;11(3):169-73.

14.

Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.

van der Graaf A, Rodenburg J, Vissers MN, Hutten BA, Wiegman A, Trip MD, Stroes ES, Wijburg FA, Otvos JD, Kastelein JJ.

J Pediatr. 2008 Jun;152(6):873-8. doi: 10.1016/j.jpeds.2007.11.043. Epub 2008 Feb 8.

PMID:
18492534
15.

Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.

Srisawasdi P, Vanavanan S, Rochanawutanon M, Pornsuriyasak P, Tantrakul V, Kruthkul K, Kotani K.

Clin Biochem. 2013 Oct;46(15):1509-15. doi: 10.1016/j.clinbiochem.2013.06.021. Epub 2013 Jul 2.

PMID:
23830843
16.

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.

Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK.

Lipids Health Dis. 2011 Oct 18;10:181. doi: 10.1186/1476-511X-10-181.

18.

High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.

Hirano T, Naito H, Kurokawa M, Ebara T, Nagano S, Adachi M, Yoshino G.

Atherosclerosis. 1996 Jun;123(1-2):57-72.

PMID:
8782837
19.

Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women.

Kasim-Karakas SE, Lane E, Almario R, Mueller W, Walzem R.

Metabolism. 1997 Apr;46(4):431-6.

PMID:
9109849
20.

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM.

J Am Coll Cardiol. 2007 Feb 6;49(5):547-53. Epub 2007 Jan 22.

Supplemental Content

Support Center